Skip to main content
Retour
Watch Compare

Telomir Pharmaceuticals, Inc.

Qualité des données : 83%
TELO
NASDAQ Manufacturing Chemicals
1,22 €
▼ 0,04 € (-3,17%)
Cap. Boursière: 43,66 M
Prix
1,27 €
Cap. Boursière
43,66 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -3,69 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-279,15%
En dessous de la moyenne du secteur (-54,44%)
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio17,51
Interest CoverageN/A

Valorisation

PE (TTM)
-4,19
En dessous de la moyenne du secteur (-1,49)
P/B Ratio6,26
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1385 pairs)
Métrique Action Médiane du Secteur
P/E -4,2 -1,5
P/B 6,3 1,6
ROE % -279,2 -54,4
Net Margin % — -41,5
Rev Growth 5Y % — 1,9
D/E — 0,3

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

Surprises de Résultats

Derniers 4 trimestres
Trimestre BPA Est. BPA Réel Surprise
Q32025 -0,07 € -0,03 € +57,1%
Q22025 -0,08 € -0,17 € -112,5%
Q12025 -0,10 € -0,07 € +30,0%
Q42024 -0,05 € -0,10 € -100,0%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -10,41 M
ROE -279,15% ROA -253,00%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -3,69 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 17,51
Interest Coverage N/A Asset Turnover N/A
Working Capital 6,98 M Tangible Book Value 6,98 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -4,19 Forward P/E N/A
P/B Ratio 6,26 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -8,45%
Market Cap 43,66 M Enterprise Value 43,66 M
Per Share
EPS (Diluted TTM) -0,33 Revenue / Share N/A
FCF / Share -0,11 OCF / Share -0,11
EPS CAGR (1Y) -158,93% EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 35,42%
SBC-Adj. FCF -8,99 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue — — —
Net Income -10,41 M -16,53 M -13,07 M
EPS (Diluted) -0,33 0,56 -0,45
Gross Profit — — —
Operating Income — — —
EBITDA — — —
R&D Expenses 2,44 M 2,24 M 1,57 M
SG&A Expenses — — —
D&A — — —
Interest Expense 4,34 M 4,34 M 1,64 M
Income Tax — — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 7,34 M 1,32 M 4,77 M
Total Liabilities 1,43 M 680 968,0 1,34 M
Shareholders' Equity 5,91 M 643 037,0 3,44 M
Total Debt — — —
Cash & Equivalents — — —
Current Assets 7,34 M 1,32 M 435 225,0
Current Liabilities 1,43 M 680 968,0 1,34 M